iodine I 131 monoclonal antibody TNT-1/B

RADIATION2 trials

Sponsors

Peregrine Pharmaceuticals, Abramson Cancer Center at Penn Medicine

Conditions

Brain and Central Nervous System Tumors

Phase 1

Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

CompletedNCT00128635

Abramson Cancer Center at Penn MedicineBrain and Central Nervous System Tumors

Start: 2005-10-31End: 2007-10-31Target: 22Updated: 2016-02-19

Phase 2

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

CompletedNCT00004017

Peregrine PharmaceuticalsBrain and Central Nervous System Tumors

Start: 2000-02-29Target: 60Updated: 2009-02-09